Cite
MLA Citation
J Wang et al.. “The effects of tislelizumab plus chemotherapy as first-line treatment on health-related quality of life of patients with advanced squamous non-small cell lung cancer: Results from a phase 3 randomized clinical trial.” Cancer treatment and research communications, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100150408668.0x000004